WTA introduces gene testing for all players on women’s tennis tour

The Women’s Tennis Association (WTA) has announced a new policy requiring all players to undergo gene testing to compete in the 2028 Los Angeles Olympics. This decision aligns with the International Olympic Committee’s guidelines and a U.S. executive order. The testing will identify the SRY gene, which is linked to male sex development, to ensure fair competition in women’s tennis. The WTA emphasizes that the policy distinguishes between biological sex and gender identity, aiming to maintain fairness without disrespecting anyone’s identity. However, this mandatory testing has faced criticism from human rights groups. QUESTION: How might mandatory gene testing in sports impact athletes’ perceptions of fairness and inclusion?